Qube Research & Technologies (QRT)
ARKG icon

Qube Research & Technologies (QRT)’s ARK Genomic Revolution ETF ARKG Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-661
Closed -$18.4K – 3660
2025
Q3 		$18.4K Buy
661
+660
+66,000% +$16.7K ﹤0.01% 3298
2025
Q2 		$24 Hold
1
– – ﹤0.01% 3504
2025
Q1 		$21 Hold
1
– – ﹤0.01% 3445
2024
Q4 		$24 Hold
1
– – ﹤0.01% 3414
2024
Q3 		$26 Hold
1
– – ﹤0.01% 3209
2024
Q2 		$23 Sell
1
-2,813
-100% -$71K ﹤0.01% 3565
2024
Q1 		$80.9K Hold
2,814
– – ﹤0.01% 3379
2023
Q4 		$92.3K Sell
2,814
-2,934
-51% -$79.8K ﹤0.01% 3126
2023
Q3 		$160K Sell
5,748
-20,878
-78% -$683K ﹤0.01% 2486
2023
Q2 		$557K Buy
26,626
+4,025
+18% +$127K ﹤0.01% 1488
2023
Q1 		$680K Sell
22,601
-34,975
-61% -$1.08M ﹤0.01% 1444
2022
Q4 		$1.63M Buy
57,576
+6,885
+14% +$219K 0.01% 1029
2022
Q3 		$1.67M Sell
50,691
-469,480
-90% -$17.2M 0.01% 1011
2022
Q2 		$16.4M Buy
520,171
+376,379
+262% +$13.2M 0.12% 215
2022
Q1 		$6.6M Buy
143,792
+141,978
+7,827% +$6.77M 0.06% 438
2021
Q4 		$111K Buy
+1,814
New +$125K ﹤0.01% 2120
2021
Q3 		– Sell
-132,712
Closed -$12.3M – 2175
2021
Q2 		$12.3M Buy
132,712
+126,930
+2,195% +$10.8M 0.14% 166
2021
Q1 		$513K Sell
5,782
-61,795
-91% -$6.13M 0.01% 1160
2020
Q4 		$6.3M Buy
67,577
+34,966
+107% +$2.79M 0.09% 255
2020
Q3 		$2.08M Buy
32,611
+14,011
+75% +$821K 0.03% 620
2020
Q2 		$970K Buy
+18,600
New +$798K 0.01% 870
2020
Q1 		– Sell
-1,400
Closed -$47K – 1115
2019
Q4 		$47K Buy
+1,400
New +$44.5K ﹤0.01% 1482

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ARKG Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 661 shares — an estimated $18.4K sold.

Qube Research & Technologies (QRT) first reported a position in ARKG in Q4 2019 and held it in 22 quarters. The position peaked at $16.4M in Q2 2022. 239 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 661 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $18.4K.
  • Qube Research & Technologies (QRT) first reported a position in ARK Genomic Revolution ETF in Q4 2019 and held it in 22 quarters.
  • Qube Research & Technologies (QRT)'s ARK Genomic Revolution ETF position peaked at $16.4M in Q2 2022.
  • 239 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.